Digital Health Interventions to Enhance Tuberculosis Treatment Adherence: Scoping Review
JMIR mHealth and uHealth · 2023
DOI: 10.2196/49741 ↗Kurz gefasst
Scoping Review in der Zeitschrift JMIR mHealth and uHealth, 2023. Verfasst von Sol Lee und 4 weiteren Autor:innen. Beteiligte Einrichtung: Yonsei University Health System, Yonsei University, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Cell Phone, Text Messaging, Tuberculosis, Telemedicine. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Digitalisierung in der Pflege
Abstract (Originalsprache)
Background
Digital health technologies are widely used for disease management, with their computing platforms, software, and sensors being used for health care. These technologies are developed to manage chronic diseases and infectious bacterial diseases, including tuberculosis (TB).
Objective
This study aims to comprehensively review the literature on the use of digital health interventions (DHIs) for enhancing TB treatment adherence and identify major strategies for their adoption.
Methods
We conducted a literature search in the PubMed, Cochrane Library, Ovid Embase, and Scopus databases for relevant studies published between January 2012 and March 2022. Studies that focused on web-based or mobile phone–based interventions, medication adherence, digital health, randomized controlled trials, digital interventions, or mobile health and ubiquitous health technology for TB treatment and related health outcomes were included.
Results
We identified 27 relevant studies and classified them according to the intervention method, a significant difference in treatment success, and health outcomes. The following interventions were emphasized: SMS text messaging interventions (8/27, 30%), medicine reminders (6/27, 22%), and web-based direct observation therapy (9/27, 33%). Digital health technology significantly promoted disease management among individuals and health care professionals. However, only a few studies addressed 2-way communication therapies, such as interactive SMS text messaging and feedback systems.
Conclusions
This scoping review classified studies on DHIs for patients with TB and demonstrated their potential for the self-management of TB. DHIs are still being developed, and evidence on the impact of digital technologies on enhancing TB treatment adherence remains limited. However, it is necessary to encourage patients’ participation in TB treatment and self-management through bidirectional communication. We emphasize the importance of developing a communication system.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Yonsei University Health System, Yonsei University, Seoul, Republic of Korea.
- Department of Healthcare Management, Graduate School of Public Health, Yonsei University, Seoul, Republic of Korea.
- Department of Human Environment & Design, Yonsei University, Seoul, Republic of Korea.
- Department of Preventive Medicine, College of Medicine, Yonsei University, Seoul, Republic of Korea.
- Institute for Innovation in Digital Healthcare, Yonsei University, Seoul, Republic of Korea.
- Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
ORCID-Profile: Sol Lee, Vasuki Rajaguru, Joon Sang Baek, Jaeyong Shin, Youngmok Park
Zitieren
APA
Lee, S., Rajaguru, V., Baek, J. S., Shin, J., & Park, Y. (2023). Digital Health Interventions to Enhance Tuberculosis Treatment Adherence: Scoping Review. JMIR mHealth and uHealth. https://doi.org/10.2196/49741
Vancouver
Lee S, Rajaguru V, Baek JS, Shin J, Park Y. Digital Health Interventions to Enhance Tuberculosis Treatment Adherence: Scoping Review. JMIR mHealth and uHealth. 2023. doi:10.2196/49741
BibTeX
@article{Lee2023,
author = {Lee, Sol and Rajaguru, Vasuki and Baek, Joon Sang and Shin, Jaeyong and Park, Youngmok},
title = {Digital Health Interventions to Enhance Tuberculosis Treatment Adherence: Scoping Review},
journal = {JMIR mHealth and uHealth},
year = {2023},
doi = {10.2196/49741}
}
EUVIMED